SCHEMBL9764352

SCHEMBL9764352

Cc1ccc2c(c1)CCN(C)C[C@@H]2c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.74
SLC6A4 P31645 3/20 0.74
SLC6A3 Q01959 3/20 0.74
DRD1 P21728 11/20 0.67
HSD17B10 Q99714 4/20 0.67
HTR2A P28223 2/20 0.67
THPO P40225 2/20 0.67
MAPK1 P28482 1/20 0.67
HIF1A Q16665 1/20 0.67
MTOR P42345 1/20 0.67
DRD2 P14416 4/20 0.65
KDM4E B2RXH2 1/20 0.65
MAPT P10636 1/20 0.65
BLM P54132 1/20 0.65
PMP22 Q01453 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CYP2D6 P10635 4/20 0.64
CYP3A4 P08684 2/20 0.64
DRD5 P21918 3/20 0.61
CYP1A2 P05177 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5246721 0.85 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3DRD1DRD2
SCHEMBL9193250 0.84 DRD1 (0.67) DRD1HSD17B10HTR2ATHPOMAPK1
SCHEMBL9193257 0.84 DRD1 (0.67) DRD1HSD17B10HTR2ATHPOMAPK1
SCHEMBL14533569 0.84 DRD1 (0.80) SLC6A2SLC6A4SLC6A3DRD1HSD17B10
SCHEMBL16263409 0.84 DRD1 (0.72) DRD1HSD17B10HTR2ATHPOMAPK1
SCHEMBL2571100 0.83 SLC6A2 (0.71) SLC6A2SLC6A4SLC6A3DRD1HSD17B10
SCHEMBL12914280 0.80 DRD1 (0.49) SLC6A2SLC6A4SLC6A3DRD1HSD17B10
SCHEMBL11712694 0.80 DRD1 (1.00) SLC6A2SLC6A4SLC6A3DRD1HSD17B10
SCHEMBL10744149 0.80 DRD1 (0.81) DRD1HSD17B10HTR2ATHPOMAPK1
SCHEMBL9764281 0.80 DRD1 (0.75) SLC6A2SLC6A4SLC6A3DRD1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996202-A 1,2,4,5 tetrahydro benzazepine-3 compounds and antipsychotic use thereof SCHERING CORPORATION (US) 1991-02-26 US disclosed